Safety and efficacy of trifluridine/tipiracil (FTD/TPI) in previously treated metastatic colorectal cancer (mCRC): Results from the Australian cohort of the phase IIIb, international, open-label, early-access PRECONNECT study

The requested reference [9ba366aa3695e849d5f3f44921cda56071ac6218] no longer exists in our database. It has been replaced by the current reference: [f7d666f89038033535c9636c8365e10a8ae8808d]

Authors
Category Primary study
JournalAnnals of oncology
Year 2020
This article has no abstract
Epistemonikos ID: ff9fb8367ab39c0a7aadf697a094b12275a56e9b
First added on: Feb 01, 2023